Open AccessSuggested risk factor for oral lichen planus arising after mRNA COVID ‐19 vaccination
Author(s) -
Zargaran Massoumeh
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6126
Subject(s) - medicine , covid-19 , vaccination , oral lichen planus , dermatology , risk factor , virology , immunology , outbreak , pathology , disease , infectious disease (medical specialty)
A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom